Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of an Individualized Ubiquitin Prognostic Signature for Clear Cell Renal Cell Carcinoma

22 Jun 2021

Abstract excerpt

Clear cell renal cell carcinoma (ccRCC) is a common tumor type in genitourinary system and has a poor prognosis. Ubiquitin dependent modification systems have been reported in a variety of malignancies and have influenced tumor genesis and progression. However, the molecular characteristics and prognostic value of ubiquitin in ccRCC have not been systematically reported. In our study, 204 differentially expressed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Renal cell carcinoma treatment
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34239875
DOI: 10.3389/fcell.2021.684643

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of an Individualized Ubiquitin Prognostic Signature for Clear Cell Renal Cell CarcinomaPMID 34239875Read ↗

Construction of an Individualized Clinical Prognostic Index Based on Ubiquitination-Associated lncRNA in Clear Cell Renal Cell Carcinoma PatientsSemantic proximity Read ↗

Deciphering potential molecular mechanisms in clear cell renal cell carcinoma based on the ubiquitin‐conjugating enzyme E2 related genes: Identifying UBE2C correlates to infiltration of regulatory T cellsSemantic proximity Read ↗

Comprehensive Analysis of the Expression and Prognosis for <i>PSMBs</i> in Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

UBE2C contributes to malignant phenotypes in clear cell renal cell carcinoma via cell cycle and apoptosis regulation.Semantic proximity Read ↗

Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.Semantic proximity Read ↗

Identification of the cuproptosis related prognostic gene signature and the associated regulation axis in clear cell renal cell carcinomaSemantic proximity Read ↗

Identification of biomarkers of clear cell renal cell carcinoma by bioinformatics analysisSemantic proximity Read ↗

Expression, Prognostic and Immunological Roles of USP8 in kidney renal clear cell carcinoma: An Integrated AnalysisSemantic proximity Read ↗

Screening and identification of key biomarkers in clear cell renal cell carcinoma based on bioinformatics analysisSemantic proximity Read ↗

A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

Bioinformatic analysis identifies potentially key differentially expressed genes in oncogenesis and progression of clear cell renal cell carcinomaSemantic proximity Read ↗

Genome‐wide screening and cohorts validation identifying novel lncRNAs as prognostic biomarkers for clear cell renal cell carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.